Summary
Current neoadjuvant chemoradiation therapy (nCRT) for locally advanced esophageal cancer (LAEC) consists of radiation with platinum/5-FU (PF) chemotherapy. However, carboplatin/paclitaxel (PT) may be a favorable chemotherapy combination with preoperative radiation. The study discussed in this article investigated whether nCRT with PT would result in better perioperative outcomes.
- Oncology Clinical Trials
- Radiation Therapy
- Radiology
- Gastrointestinal Cancers
- Oncology Clinical Trials
- Radiation Therapy
- Radiology
- Oncology
- Gastrointestinal Cancers
- © 2014 MD Conference Express®
Tools
Table of contents
Cited By...
- No citing articles found.